看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 21.4x - 23.6x | 22.5x |
| Selected Fwd EBIT Multiple | 19.0x - 21.0x | 20.0x |
| Fair Value | ﷼71.07 - ﷼78.27 | ﷼74.67 |
| Upside | -5.2% - 4.4% | -0.4% |
| Benchmarks | Ticker | Full Ticker |
| National Medical Care Company | 4005 | SASE:4005 |
| Naba Al Saha Medical Services Company | 9546 | SASE:9546 |
| Saudi Chemical Holding Company | 2230 | SASE:2230 |
| Middle East Healthcare Company | 4009 | SASE:4009 |
| Professional Medical Expertise Company | 9574 | SASE:9574 |
| Balsm Alofoq Medical Company | 9620 | SASE:9620 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 4005 | 9546 | 2230 | 4009 | 9574 | 9620 | ||
| SASE:4005 | SASE:9546 | SASE:2230 | SASE:4009 | SASE:9574 | SASE:9620 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 23.6% | NM- | 28.9% | 33.7% | NM- | NM- | |
| 3Y CAGR | 15.7% | 16.7% | 45.3% | 101.1% | 42.0% | NM- | |
| Latest Twelve Months | 3.2% | -42.4% | 37.8% | 36.1% | 22.1% | NM | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 19.2% | 21.8% | 5.2% | 8.3% | 14.8% | 22.6% | |
| Prior Fiscal Year | 22.8% | 24.0% | 6.5% | 12.2% | 14.8% | 22.0% | |
| Latest Fiscal Year | 19.7% | 13.0% | 6.8% | 15.3% | 13.3% | 24.1% | |
| Latest Twelve Months | 19.7% | 13.0% | 6.8% | 15.3% | 13.6% | 21.5% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.04x | 3.85x | 1.39x | 2.94x | 1.58x | 4.81x | |
| EV / LTM EBITDA | 20.7x | 21.8x | 18.3x | 13.5x | 10.4x | 18.4x | |
| EV / LTM EBIT | 25.6x | 29.6x | 20.4x | 19.2x | 11.6x | 22.4x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 11.6x | 20.4x | 29.6x | ||||
| Historical EV / LTM EBIT | 0.0x | NM | 0.0x | ||||
| Selected EV / LTM EBIT | 21.4x | 22.5x | 23.6x | ||||
| (x) LTM EBIT | 4 | 4 | 4 | ||||
| (=) Implied Enterprise Value | 86 | 91 | 96 | ||||
| (-) Non-shareholder Claims * | 3 | 3 | 3 | ||||
| (=) Equity Value | 90 | 94 | 99 | ||||
| (/) Shares Outstanding | 1.3 | 1.3 | 1.3 | ||||
| Implied Value Range | 71.78 | 75.42 | 79.06 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 71.78 | 75.42 | 79.06 | 75.00 | |||
| Upside / (Downside) | -4.3% | 0.6% | 5.4% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4005 | 9546 | 2230 | 4009 | 9574 | 9620 | |
| Enterprise Value | 6,532 | 738 | 8,794 | 8,393 | 444 | 90 | |
| (+) Cash & Short Term Investments | 567 | 43 | 130 | 52 | 7 | 5 | |
| (+) Investments & Other | 0 | 2 | 2 | 60 | 0 | 0 | |
| (-) Debt | (488) | (89) | (1,587) | (2,466) | (101) | (2) | |
| (-) Other Liabilities | 0 | 0 | (12) | (48) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 6,611 | 693 | 7,327 | 5,992 | 350 | 94 | |
| (/) Shares Outstanding | 44.9 | 10.5 | 843.2 | 92.0 | 3.5 | 1.3 | |
| Implied Stock Price | 147.40 | 66.00 | 8.69 | 65.10 | 100.00 | 75.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 147.40 | 66.00 | 8.69 | 65.10 | 100.00 | 75.00 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |